Enzo Biochem (ENZ) 10-Q2023 Q1 Quarterly report

Filed: 12 Dec 22, 5:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AAA, advisory, arbitration, arbitrator, ASC, assignee, bank, chosen, civil, Clerk, compel, constituted, criteria, directed, disagreed, disputed, distinct, dramatically, driven, elapsed, enforceable, event, forgiven, fully, hearing, lag, lender, longer, maximum, met, necessity, panel, Paycheck, PPP, prepaid, proceeding, promise, promised, purpose, questionnaire, reactivation, redirect, referenced, request, requested, resource, retain, salary, SBA, semiannual, significantly, Small, successfully, sufficient, target, technical, threshold, title, unconditional, version, voluntary, week, withhold, withholding, workforce

Removed: Accelerated, accrue, active, adjourn, advance, amending, AMPIPROBE, announcing, application, appointed, arose, automated, aware, backed, broader, capacity, chain, clarifying, classified, CMS, collected, contemplated, content, continuing, convene, curtail, curtailing, database, decided, declared, deemed, depend, derive, earning, economy, eliminated, Erfanian, ETF, evolving, exclusive, exit, expansion, extraction, finite, Food, GENFLEX, Hamid, hamper, hierarchy, highest, highly, hold, identical, innovative, insignificant, intersegment, invested, kit, knowledge, law, lowest, media, municipal, mutual, observable, orderly, persist, personnel, pooled, priority, promulgated, provision, publicly, quoted, rated, recoupment, recoverable, recovery, reflect, remitted, removing, repay, satisfy, science, sequential, serological, simplify, Simplifying, specimen, speed, supply, swab, traded, uncollectable, unobservable, voluntarily, winding

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated ENZ transcripts

ENZ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
TITLE 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Enzo Biochem, Inc., and Subsidiaries (“the Company”) on Form 10-Q for the period ended October 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Hamid Erfanian, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: December 12, 2022

	By:	/s/ Hamid Erfanian
		Hamid Erfanian
		Chief Executive Officer